Earlier this month, the Pain Management Best Practices Inter-Agency Task Force held its third and last public meeting, voting to adopt its final draft recommendations for acute and chronic pain management.
Uncategorized
New Federal Policy Could Limit Non-Opioid Pain Treatments
Treating pain without opioids has become possible for many patients through novel drugs approved by a regulatory process called 505(b)(2). Now, access to these treatments is in jeopardy.
